Researcher
Joost Wauters
- Disciplines:Laboratory medicine, Palliative care and end-of-life care, Other basic sciences, Other health sciences, Nursing, Other paramedical sciences, Regenerative medicine, Other translational sciences, Other medical and health sciences
Affiliations
- Laboratory for Clinical Infectious and Inflammatory Disorders (Division)
Responsible
From1 Oct 2023 → Today - Processing Speech and Images (PSI) (Division)
Member
From1 Aug 2020 → 30 Jun 2000 - Laboratory of Intensive Care Medicine (Division)
Member
From1 Jan 2009 → 30 Sep 2011 - Laboratory for Clinical Infectious and Inflammatory Disorders (Division)
Member
From1 Dec 2004 → Today - ESAT - PSI, Processing Speech and Images (Division)
Member
From1 Nov 1999 → 30 Jun 2000 - Department of Electrical Engineering (ESAT) (Department)
Member
From1 Oct 1999 → 31 Jan 2000
Projects
1 - 10 of 21
- From bed to bench and back in viral-associated pulmonary aspergillosis: generation of pathophysiological insight and translation into host-based biomarkersFrom1 Oct 2023 → TodayFunding: FWO fellowships
- Unraveling the pathophysiology of Virus-Associated Pulmonary Aspergillosis using zebrafishFrom1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- A novel integrated multi-omics based approach to the management of viral-associated pulmonary aspergillosis (VAPA)From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- STRAtified Dosing based on Augmented renal clearance for CEFtriaxone in patients with severe community-acquired pneumonia: STRADA-CEF trial.From1 Oct 2022 → TodayFunding: FWO Applied Biomedical Research (TBM)
- Unraveling the pathophysiology of Virus-Associated Pulmonary Aspergillosis: viruses and fungi combine efforts to make a perfect stormFrom19 Sep 2022 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Mold-active Azoles: Development, Validation and Implementation of strategies for Safe and Effective Dosing (M-ADVISED)From1 Oct 2021 → TodayFunding: FWO Strategic Basic Research Grant
- Clinical validation of antifungal dosing strategies in critically ill patientsFrom1 Oct 2021 → 30 Sep 2022Funding: BOF - postdoctoral mandates
- The co-pathogenesis of severe influenza with invasive pulmonary aspergillosis.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Dual-band fibered confocal fluorescence microscope for the intravital interrogation of deep tissues and organs in real time and with cellular resolutionFrom1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Development and streamlining a validation and implementation workflow for model-informed precision dosing for biologicals and antimicrobialsFrom1 Oct 2020 → 30 Sep 2022Funding: IOF - technology validation in lab
Publications
1 - 10 of 137
- A good start is half the battle: Antibiotic IV line residuals in the intensive care unit.(2024)
Authors: Dorian Vanneste, Yves Debaveye, Joost Wauters
Pages: 103663 - Fungal Fog in Viral Storms: Necessity for Rigor in Aspergillosis Diagnosis and Research.(2024)
Authors: Simon Feys, Joost Wauters
Pages: 631 - 633 - Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study.(2024)
Authors: Simon Feys, Sam Vanmassenhove, Bram Boeckx, Seppe Cambier, Yves Debaveye, Greet Hermans, Katrien Lagrou, Johan Neyts, Marijke Peetermans, Joana Duarte Da Rocha Pereira, et al.
Pages: e247 - e260 - High Burden of COVID-19-Associated Pulmonary Aspergillosis in Severely Immunocompromised Patients Requiring Mechanical Ventilation(2024)
Authors: Simon Feys, Katrien Lagrou, Yves Debaveye, Greet Hermans, Johan Maertens, Marijke Peetermans, Robin Vos, Eric Van Wijngaerden, Alexander Wilmer, Joost Wauters
- Acute Invasive Pulmonary Aspergillosis: Clinical Presentation and Treatment(2024)
Authors: Jannes Heylen, Johan Maertens, Joost Wauters
- Clinical and molecular epidemiological features of critically ill patients with invasive group A Streptococcus infections: a Belgian multicenter case-series(2024)
Authors: Marijke Peetermans, Michael Casaer, Yves Debaveye, Stefanie Desmet, Greet Hermans, Joost Wauters
- Optimizing Azithromycin use in Respiratory Diseases: From COVID-19 to COPD “A comprehensive evaluation and Personalized Treatment Approach”(2024)
Authors: Iwein Gyselinck, Wim Janssens, Joost Wauters
- The value of point-of-care tests for the detection of SARS-CoV-2 RNA or antigen in bronchoalveolar lavage fluid(2024)
Authors: Jan Van Slambrouck, Lies Laenen, Xin Jin, Joost Wauters, Geert Molenberghs, Bart Vanaudenaerde, Robin Vos, Katrien Lagrou, Laurens Ceulemans
- Population Pharmacokinetics of Total and Unbound Isavuconazole in Critically Ill Patients: Implications for Adaptive Dosing Strategies(2023)
Authors: Beatrijs Mertens, Joost Wauters, Yves Debaveye
- Complications related to extracorporeal life support in lung transplantation: single-center analysis(2023)
Authors: Jan Van Slambrouck, Christelle Vandervelde, Julie De Beule, Paul De Leyn, Hans Van Veer, Lieven Depypere, Geert Verleden, Laurent Godinas, Robin Vos, Erwin De Troy, et al.
Pages: 6301 - 6316